E I Pyott David Exercises Options at Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 12, 2026
SEC Form 4 · No Market Transaction
Option Exercise
Derivative exercise — no open market transaction.
Equity Position
33.3K sh
29,482 → 33,262
Equity Change
+12.8%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| E I Pyott David CIK 0001051578 |
Director
|
E I Pyott David at Alnylam Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$1,145,853
More from this insider at Alnylam Pharmaceuticals Inc
| 2026-06-03 | Sell | -$1,145,853 | View |
| 2026-05-22 | Award | — | View |
| 2025-05-12 | Award | — | View |
| 2025-03-25 | Sell | -$2,224,560 | View |
| 2024-06-26 | Sell | -$7,161,360 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-11-10 | M - Exercise | 3,780 A | $71.99 | +$272,122 | 5,362 | Direct |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $71.99 | 2026-11-10 | M - Exercise | 3,780 D | $0.00 | 2027-06-01 | 3,780 Common Stock | Direct |
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Common StockF2 | 27,900 | Indirect by Trust |
Footnotes (2)
Related filings at Alnylam Pharmaceuticals Inc
Institutional Holders
13F holders · Sep 30, 2026
721
institutional managers reporting a position
Largest by reported value
- Capital World Investors $3.41B
- Fmr Llc $3.11B
- Black Rock, Inc. $2.72B
5%+ Holders · 13D/G
6 filers
Other insiders at Alnylam Pharmaceuticals Inc
GET /v1/forms/4/0001178670-26-000089
API docs
View Original SEC Filing